LGD-2226

Details

Stereochemistry	ACHIRAL
Molecular Formula	C14H9F9N2O
Molecular Weight	392.2197
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

FC(F)(F)CN(CC(F)(F)F)C1=CC2=C(NC(=O)C=C2C(F)(F)F)C=C1

InChI

InChIKey=ULBPQWIGZUGPHU-UHFFFAOYSA-N

InChI=1S/C14H9F9N2O/c15-12(16,17)5-25(6-13(18,19)20)7-1-2-10-8(3-7)9(14(21,22)23)4-11(26)24-10/h1-4H,5-6H2,(H,24,26)

HIDE SMILES / InChI

Approval Year

PubMed

Show entries

Title	Date	PubMed
Structure of the ligand-binding domain (LBD) of human androgen receptor in complex with a selective modulator LGD2226.	2006 Nov 1	17077481
An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.	2007 Jan	17023534
Cell-specific activation of the human skeletal alpha-actin by androgens.	2008 Mar	18063690

Showing 1 to 3 of 3 entries

Previous1Next

Patents

Show entries

Name

Type

Language

LGD-2226

Common Name

English

6-(BIS-(2,2,2-TRIFLUOROETHYL)AMINO)-4-TRIFLUOROMETHYL-1H-QUINOLIN-2-ONE

Systematic Name

English

Showing 1 to 2 of 2 entries

Previous1Next

Show entries

Classification Tree

Code System

Code

Androgens

WIKIPEDIA

Designer-drugs-LGD-2226

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Code System

Code

Type

Description

WIKIPEDIA

LGD-2226

PRIMARY

FDA UNII

RI376RM5MT

PRIMARY

EPA CompTox

DTXSID10186546

PRIMARY

DRUG BANK

DB08089

PRIMARY

PUBCHEM

11560224

PRIMARY

Showing 1 to 5 of 6 entries

Previous1 2Next

SUBSTANCE RECORD


					RI376RM5MT

LGD-2226